Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment crawled time : 01:00 save search
Mass Flow Controllers Global Strategic Business Report 2024 - Mass Flow Controllers Gain Traction in Water & Wastewater Treatment Programs
Published: 2024-04-02 (Crawled : 01:00) - prnewswire.com
MKSI | $108.1 -3.56% -3.69% 770K
|
Electronic Technology
|
| O: -1.96%
H: 0.05%
C: -0.38%
water report business treatment global flow
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: 10.27%
H: 0.4%
C: -25.91%
vafseo fda disease kidney anemia approval treatment dialysis
Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients
Published: 2024-03-20 (Crawled : 01:00) - prnewswire.com
CALT | $17.65 -2.4% 4K
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
nefegan nephropathy health treatment sciences
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
Published: 2024-03-11 (Crawled : 01:00) - prnewswire.com
SGMT | $4.0 0.76% 0.75% 430K
|
Health Technology
|
| O: 1.04%
H: 2.24%
C: -5.68%
asc40 presentation treatment meeting acne results study
Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Published: 2024-02-08 (Crawled : 01:00) - globenewswire.com
TENX | $3.62 -1.63% -1.66% 14K
|
Health Technology
|
| O: -64.03%
H: 9.16%
C: -1.17%
tnx-103 first treatment hypertension heart therapeutics study
Global Atherectomy Devices Market Report 2023-2030: Minimally Invasive Treatment Options Surge in Demand, Key Players Boston Scientific, Abbott, and Medtronic Shape the Landscape
Published: 2024-01-09 (Crawled : 01:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
TRUMY | $16.507 0.79% 34K
|
Manufacturing
|
| O: 4.99%
H: 0.29%
C: -2.67%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.16%
H: 1.86%
C: 0.27%
ITGR | $116.62 -1.03% 0.0% 450K
|
Producer Manufacturing
|
| O: -1.35%
H: 2.08%
C: 1.1%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: -0.38%
H: 2.06%
C: 1.77%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.22%
H: 1.1%
C: -3.78%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
report treatment global key market
Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.89%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.16%
H: 0.52%
C: -0.64%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 1.05%
H: 2.38%
C: 0.81%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 4.96%
H: 1.5%
C: 0.91%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
stroke reach treatment research market
CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 0.0%
H: 0.14%
C: 0.14%
hemgenix treatment living
Treatment with CARVYKTI® (ciltacabtagene autoleucel) Resulted in Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Disease-Specific Symptoms in Patients with Earlier-Line Multiple Myeloma
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
carvykti life treatment
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.2%
H: 1.7%
C: 1.3%
rient-16 treatment results study
Drugs For Benign Prostatic Hypertrophy Market Report 2024 - Market to Reach $5.45 billion in 2028 - Opportunities in Minimally Invasive Treatments, Personalized Medicine and Combination Therapies
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: -1.01%
H: 14.29%
C: 13.27%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
report reach market
Robot-Assisted Systems and Software Lead Robotic Dentistry Market, Offering Accurate and Efficient Dental Treatment Solutions
Published: 2023-11-02 (Crawled : 01:00) - prnewswire.com
NVST | $19.96 1.06% 0.0% 1.2M
|
Health Technology
|
| O: -11.92%
H: 8.4%
C: 4.94%
ISRG | $366.1 -1.75% -1.78% 3.8M
|
Health Technology
|
| O: 1.52%
H: 1.3%
C: 1.21%
ALGN | $298.99 -0.78% -0.79% 520K
|
Health Technology
|
| O: 3.13%
H: 2.41%
C: 1.78%
software offering treatment dental solutions
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease
Published: 2023-10-02 (Crawled : 01:00) - prnewswire.com
FOLD F | $10.62 2.81% 2.73% 2.5M
|
Health Technology
|
| O: -0.66%
H: 0.66%
C: -8.69%
fda disease approval treatment therapeutics
Wegener's Granulomatosis Treatment Market on the Rise: Increased Awareness and Advancements Drive Projected 5.9% CAGR Growth by 2031
Published: 2023-09-19 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.47%
C: 0.41%
SNOA | $0.1539 -1.72% -1.75% 170K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.29%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.18%
H: 1.89%
C: 1.51%
treatment growth market
Global Alport Syndrome Treatment Market Set to Surge, Projected to Reach USD 19.00 Million by 2032
Published: 2023-08-31 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
reach treatment global set market
Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy
Published: 2023-08-21 (Crawled : 01:00) - prnewswire.com
CALT | $17.65 -2.4% 4K
|
Health Technology
|
| O: 8.17%
H: 1.41%
C: -1.69%
nefecon fda nephropathy approval review treatment therapeutics
Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.99%
H: 1.45%
C: 1.36%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 2.02%
H: 0.72%
C: -0.49%
treatment global market
United Kingdom Biocides Markets Report 2023-2028: From Water Treatment to Agriculture - Diverse End-Use Industries Fuels Market Growth
Published: 2023-08-09 (Crawled : 01:00) - prnewswire.com
ALB | $112.15 0.31% -0.13% 2M
|
Process Industries
|
| O: 0.94%
H: 0.0%
C: 0.0%
water report treatment agriculture growth market
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2023-07-17 (Crawled : 01:00) - prnewswire.com
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -1.28%
H: 4.55%
C: -0.65%
xpovio approval treatment
Global Hearing Loss Disease Treatment Market Report 2023: Rising Prevalence of Hearing Loss Drives Growth
Published: 2023-06-15 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.04%
H: 0.78%
C: 0.67%
disease report treatment global growth market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.